ARROWHEAD PHARMACEUTICALS: INTENDS TO SUBMIT A SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) TO FDA BY YEAR-END 2026

Reuters · 4d ago

Please log in to view news